跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rispegard - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rispegard
Approved
STANDARD
Rispegard
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ee6846f5e693cd74
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
ee6846f5e693cd74
Drug Approval Philippines Name
Rispegard
Product Name
Rispegard
Registration Number
DR-XY45340
Brand Name
Rispegard
Generic Name
Risperidone
Dosage Form
Oral Solution
Dosage Strength
1 mg/mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Vitalink Health Products, Inc.
Issuance Date
27 May 2021
Expiry Date
29 April 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ee6846f5e693cd74
Type
Standard
Back to Philippines FDA Approvals